Cargando…
Retrospective validation of the postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria in a Swiss cohort
BACKGROUND: Currently used screening criteria for retinopathy of prematurity (ROP) show high sensitivity for predicting treatment-requiring ROP but low specificity; over 90% of examined infants do not develop ROP that requires treatment (type 1 ROP). A novel weight gain-based prediction model was de...
Autores principales: | Vinayahalingam, Nithursa, McDougall, Jane, Ahrens, Olaf, Ebneter, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751318/ https://www.ncbi.nlm.nih.gov/pubmed/35012498 http://dx.doi.org/10.1186/s12886-021-02227-4 |
Ejemplares similares
-
Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) Study
por: Zupancic, John A. F., et al.
Publicado: (2020) -
Treatment of retinopathy of prematurity (ROP)
por: Rajan, Renu Puthenvilayil, et al.
Publicado: (2018) -
Treatment of retinopathy of prematurity (ROP)
por: Rajan, Renu Puthenvilayil, et al.
Publicado: (2017) -
Validation of the Postnatal Growth and Retinopathy of Prematurity (GROP) screening criteria
por: Fadakar, Kaveh, et al.
Publicado: (2022) -
Survey on retinopathy of prematurity (ROP) in Italy
por: Borroni, Cesarina, et al.
Publicado: (2013)